Proactive Investors - Run By Investors For Investors

Instem appoints former PAREXEL luminary as COO

MaryBeth Thompson has more than 18 years of experience in the life sciences industry
Management appointment
Prior to PAREXEL, Thompson worked for AstraZeneca and Wyeth-Ayerst Laboratories

Life sciences industry veteran MaryBeth Thompson has been appointed as chief operating officer of Instem Plc (LON:INS), the clinical trials software services provider.

Thompson will report to chief executive officer Phil Reason, but will not sit on the board.

She has more than 18 years of experience in the life sciences industry, with a primary focus in regulatory affairs and operations with a demonstrable track record as a leader and builder of outsourcing services businesses, Instem said.

Thompson previously worked at PAREXEL International, the multi-national life sciences consulting firm, where she established and expanded the regulatory outsourcing services practice from a US$1 million revenue business with 30 employees to an international organisation across the US, Europe and India with more than US$30 million of revenues and 300 employees.

“We are delighted to have appointed someone of MaryBeth's calibre and experience to Instem,” said Reason.

“MaryBeth has a strong track record in building life sciences businesses and we look forward to the benefits she will bring as we embark upon the company's next phase of growth," the CEO added.

Why Invest In Instem Plc? Read More Here

Register here to be notified of future INS Company articles
View full INS profile

Instem Plc Timeline

Big Picture
September 19 2016

Related Articles

September 25 2016
Bournemouth-based Modrus will be modestly earnings in the first financial year and add significantly more to the bottom line in the second.
The top line was driven primarily by the strong growth of the company's Risk Management and Trading Software Division
Kevin Spacey holding a blood sample
September 19 2016
Instem currently has more than 500 clients across the globe. It reports a 98% client retention rate, which it says is a “true measure of our success”.

© Proactive Investors 2017

Proactive Investor UK Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use